NFKB1 and acute myeloid leukemia: In addition, many cases of AML show increased activation of the survival-signaling pathway mediated by NF-κB [26], particularly the leukemic stem cell component, and importantly, it has been shown that leukemic stem cells are more susceptible to bortezomib-induced apoptosis than their normal counterparts [27].